Literature DB >> 21680183

Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.

Monika Jagrat1, Jagannath Behera, Samiye Yabanoglu, Ayse Ercan, Gulberk Ucar, Barij Nayan Sinha, Vadivelan Sankaran, Arijit Basu, Venkatesan Jayaprakash.   

Abstract

Twenty-two pyrazoline derivatives were synthesized and tested for their human MAO (hMAO) inhibitory activity. Twelve molecules with unsubstituted ring A and substituted ring C (5-16) were found to be potent inhibitors of hMAO-A isoform with SI(MAO-A) in the order 10(3) and 10(4). Ten molecules with unsubstituted ring A and without ring C (21-30), in which eight molecules (21, 23-26, and 28-30) were selective for hMAO-A, one for hMAO-B (22) and the other one non-selective (27). Presence of ring C increases potency as well as SI towards hMAO-A; however its absence decreases both potency and SI towards hMAO-A and hMAO-B.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680183     DOI: 10.1016/j.bmcl.2011.05.057

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis.

Authors:  Vishnu Nayak Badavath; İpek Baysal; Gulberk Ucar; Barij Nayan Sinha; Venkatesan Jayaprakash
Journal:  ACS Med Chem Lett       Date:  2015-12-01       Impact factor: 4.345

2.  Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A.

Authors:  Chandrani Nath; Vishnu Nayak Badavath; Abhishek Thakur; Gulberk Ucar; Orlando Acevedo; Mohd Usman Mohd Siddique; Venkatesan Jayaprakash
Journal:  Medchemcomm       Date:  2018-06-08       Impact factor: 3.597

3.  Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336.

Authors:  Charles Edwin Raja Gabriel; Trung T Nguyen; Emanuele Marco Gargano; Jed F Fisher; Mayland Chang; Shahriar Mobashery
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-06

4.  N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies.

Authors:  Avinash C Tripathi; Savita Upadhyay; Sarvesh Paliwal; Shailendra K Saraf
Journal:  EXCLI J       Date:  2018-01-19       Impact factor: 4.068

5.  Design, Synthesis, Docking Studies and Monoamine Oxidase Inhibition of a Small Library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles.

Authors:  Paolo Guglielmi; Simone Carradori; Giulio Poli; Daniela Secci; Roberto Cirilli; Giulia Rotondi; Paola Chimenti; Anél Petzer; Jacobus P Petzer
Journal:  Molecules       Date:  2019-01-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.